Use of finerenone for heart failure with preserved ejection fraction carries a hyperkalemia risk, especially in patients with kidney disease.

Hyperkalemia (>5.5 mEq/L ... For congestive heart failure post-myocardial infarction, treatment is initiated at 25 mg once daily and titrated to a target of 50 mg once daily within 4 weeks.

People with type 2 diabetes had significantly fewer heart attacks, strokes, heart failures, and deaths from cardiovascular ...

Received 693 new patient start forms for FILSPARI® (sparsentan) in the fourth quarter of 2024; approximately $50 million in preliminary net ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Potassium (as chloride) 20mEq/packet; pwd for oral soln; orange flavor. Take with meals and fluids. Swallow tabs whole; may break Klor-Con M tabs in half, or mix in 4oz water. Effervescent tabs ...

Lead researcher Woon-Puay Koh, a professor at NUS Medicine, added ... with some form of chronic kidney disease developed hyperkalemia and required intensive care unit hospitalization after ...

The message is that an early decrease in eGFR with finerenone should not lead to stopping the medication, say HF experts.

Laser treatment was not available at the treating ... induced by the bicarbonate corrects the metabolic acidosis and hyperkalemia associated with massive transfusions. Intravenous furosemide ...

Treatment was continued until one of the following ... pneumonitis, hyperglycemia, hyperkalemia, hemorrhage, and diarrhea reported in over 1% of patients. Common adverse reactions (≥ 10% of ...

Discover whether you can drink electrolytes every day, if it's possible to take too many electrolytes, who should avoid these ...